Ginsenoside Rg1 Suppresses Non-Small-Cell Lung Cancer via MicroRNA-126-PI3K-AKT-mTOR Pathway.

Chen P, Li X, Yu X, Yang M

Open source

DOI
10.1155/2022/1244836
Published
2022
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/1244836,
  title = {Ginsenoside Rg1 Suppresses Non-Small-Cell Lung Cancer via MicroRNA-126-PI3K-AKT-mTOR Pathway.},
  author = {Chen P and Li X and Yu X and Yang M},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/1244836},
  url = {https://doi.org/10.1155/2022/1244836}
}

RIS

TY  - JOUR
TI  - Ginsenoside Rg1 Suppresses Non-Small-Cell Lung Cancer via MicroRNA-126-PI3K-AKT-mTOR Pathway.
AU  - Chen P
AU  - Li X
AU  - Yu X
AU  - Yang M
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/1244836
UR  - https://doi.org/10.1155/2022/1244836
ER  - 

APA

P, C., X, L., X, Y., & M, Y. (2022). Ginsenoside Rg1 Suppresses Non-Small-Cell Lung Cancer via MicroRNA-126-PI3K-AKT-mTOR Pathway.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/1244836

Source records